.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chime & Chill has shown varied performance across different categories and states, with interesting trends emerging in the New York market. In the Tincture & Sublingual category, the brand held a steady presence, ranking 12th in December 2025 and 13th in January 2026. However, by February and March 2026, Chime & Chill did not appear in the top 30 rankings, indicating a potential decline in market presence or increased competition within the category. This shift suggests that while the brand maintained a notable position at the end of 2025, it faced challenges in sustaining its rank into the early months of 2026.
Despite the absence from the top 30 in February and March, the sales figures for December 2025 and January 2026 provide a glimpse into the brand's market performance. The sales dropped from 13,034 units in December to 11,542 units in January, which could be indicative of seasonal fluctuations or changes in consumer preferences. The lack of data for subsequent months makes it difficult to ascertain whether this trend continued, but the initial decline suggests that Chime & Chill might need to reassess its strategies to regain its foothold in the New York market. The absence from the rankings in later months could be seen as a challenge the brand needs to address to enhance its visibility and performance in the competitive cannabis market.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Chime & Chill has experienced fluctuations in its market positioning. As of December 2025, Chime & Chill was ranked 12th, but by January 2026, it had slipped to 13th place. This decline in rank coincides with a decrease in sales from December to January. Notably, Papa & Barkley maintained a strong presence, securing the 9th position in December 2025, although their subsequent ranks are not available, suggesting they dropped out of the top 20. Meanwhile, 7 SEAZ emerged in February and March 2026, consistently holding the 12th position, which might indicate a growing preference among consumers. The data suggests that Chime & Chill faces stiff competition, particularly from brands like 7 SEAZ, which have shown resilience and potential growth in the New York market.
Notable Products
In March 2026, the top-performing product for Chime & Chill was the KO - CBD Double Dose Tincture (4500mg CBD, 30ml) in the Tincture & Sublingual category, maintaining its first-place rank consistently since December 2025, despite a decrease in sales to 181 units. The KO- CBD The Money Melon Distillate Disposable (1g) in the Vapor Pens category climbed to second place from third in the previous two months, showing a notable increase in sales. The CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) in the Topical category held steady at third place, with a significant rise in sales figures. Mango Tango Live Resin Gummies 10-Pack (100mg) in the Edible category slipped to fourth place from its debut at second in February 2026. Lastly, the CBD Hello Honeydew Live Resin Cartridge (1g) in the Vapor Pens category dropped to fifth place from a second-place rank in January, with fluctuating sales throughout the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
